Takeda: all 1,753 studies

Page 16 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled TrialCompletedNCT01020825
• Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe HypertensionCompletedNCT01012479Phase 4
• Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate AdenocarcinomaCompletedNCT01011751Phase 3
• Dose Escalation Study of MLN4924 in Adults With MelanomaCompletedNCT01011530Phase 1
• Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes MellitusCompletedNCT01007097Phase 2
• Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic ConstipationCompletedNCT00987844Phase 3
• Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys BullosaCompletedNCT00987142Phase 2
• Norwalk Vaccine StudyCompletedNCT00973284Phase 1/2
• FST-201 in the Treatment of Acute Otitis ExternaCompletedNCT00961675Phase 3
• Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher DiseaseApproved for marketingNCT00954460
• Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 DiabetesCompletedNCT00949091Phase 1
• Study of TAK-733 in Adult Patients With Advanced Nonhematologic MalignanciesCompletedNCT00948467Phase 1
• FST-201 In The Treatment of Acute Otitis ExternaTerminatedNCT00945802Phase 3
• FST-201 In The Treatment of Acute Fungal Otitis ExternaTerminatedNCT00945646Phase 3
• FST-100 Ophthalmic Suspension in Acute Adenoviral ConjunctivitisTerminatedNCT00941486Phase 2
• Study of TAK-901 in Adults With Advanced Solid Tumors or LymphomaCompletedNCT00935844Phase 1
• The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00928148Phase 2
• Efficacy and Safety of Ramelteon on Chronic InsomniaCompletedNCT00915135Phase 2
• MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic LeukemiaCompletedNCT00911066Phase 1
• Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma MultiformeWithdrawnNCT00904852Phase 1
• Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG ParametersCompletedNCT00903747Phase 1
• Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat AcetateCompletedNCT00890448
• Safety of Lapaquistat Acetate in Subjects With HypercholesterolemiaCompletedNCT00868127Phase 3
• Efficacy of Lapaquistat Acetate in Subjects With HypercholesterolemiaTerminatedNCT00865228Phase 2
• Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With HypercholesterolemiaCompletedNCT00864643Phase 2
• Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart FailureTerminatedNCT00843154Phase 3
• Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological MalignanciesCompletedNCT00831896Phase 1
• A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of TeduglutideCompletedNCT00820885Phase 1
• Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy ParticipantsCompletedNCT00819468Phase 1
• Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,cCompletedNCT00817739Phase 2
• Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand DiseaseCompletedNCT00816660Phase 1
• Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol LevelsCompletedNCT00813527Phase 2
• A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesCompletedNCT00807677Phase 1
• Safety Study of Prucalopride in Healthy VolunteersCompletedNCT00793429Phase 1
• Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)CompletedNCT00793247Phase 2
• Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV SubcutaneouslyCompletedNCT00782106Phase 1/2
• A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.CompletedNCT00776074Phase 2
• Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.CompletedNCT00775840Phase 3
• Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.CompletedNCT00775814Phase 4
• Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced CancerCompletedNCT00773929Phase 1
• Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 DiabetesCompletedNCT00772174Phase 3
• Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.CompletedNCT00771004Phase 2
• Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00770952Phase 3
• Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.CompletedNCT00770835Phase 4
• Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.CompletedNCT00770640Phase 2
• Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular DiseaseCompletedNCT00770575Phase 2
• Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.CompletedNCT00770497Phase 2
• Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.CompletedNCT00770445Phase 4
• Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00763347Phase 2
• Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00763022Phase 3
• Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.TerminatedNCT00762957Phase 3
• Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00762736Phase 2
• Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762684Phase 3
• Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762190Phase 3
• Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762112Phase 3
• Efficacy and Safety of TAK-783 in Subjects With Rheumatoid ArthritisCompletedNCT00760968Phase 2
• Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral NeuropathyCompletedNCT00760955Phase 2
• Safety and Efficacy of TAK-715 in Subjects With Rheumatoid ArthritisCompletedNCT00760864Phase 2
• Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes MellitusCompletedNCT00760344Phase 2
• Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.TerminatedNCT00759720Phase 3
• Efficacy and Safety of Azilsartan in Subjects With Essential HypertensionCompletedNCT00759551Phase 2
• Safety Study of TAK-128 in Subjects With Diabetic Peripheral NeuropathyTerminatedNCT00756041Phase 2
• Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With InsomniaCompletedNCT00755508Phase 2
• Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic InsomniaCompletedNCT00755495Phase 2
• Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 DiabetesCompletedNCT00754403Phase 4
• Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes MellitusTerminatedNCT00722917Phase 2
• Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple MyelomaCompletedNCT00722488Phase 1
• Double-Blind, Randomized, Placebo-Controlled Trial of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular DiseaseCompletedNCT00715169Phase 2
• Study of MLN4924 in Adult Patients With Nonhematologic MalignanciesCompletedNCT00677170Phase 1
• Safety and Efficacy of TAK-442 in Subjects With Acute Coronary SyndromesCompletedNCT00677053Phase 2
• Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With InsulinCompletedNCT00676260Phase 2
• Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.CompletedNCT00672919Phase 4
• Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary DiseaseCompletedNCT00672802Phase 2
• Efficacy of Ramelteon in Adults With Chronic InsomniaTerminatedNCT00672724Phase 3
• Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep ApneaCompletedNCT00672061Phase 2
• Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug AbuseCompletedNCT00671632Phase 2
• Ramelteon in Adults With Chronic InsomniaCompletedNCT00671567Phase 3
• Efficacy of Ramelteon on Transient Insomnia in Healthy AdultsCompletedNCT00671398Phase 3
• Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.CompletedNCT00671294Phase 3
• Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic InsomniaCompletedNCT00671255Phase 3
• Safety and Efficacy of Ramelteon in Healthy SubjectsCompletedNCT00671190Phase 2
• Study of Efficacy of Ramelteon in Adults With Chronic InsomniaCompletedNCT00671125Phase 3
• Efficacy of Ramelteon in Subjects With Chronic InsomniaCompletedNCT00671086Phase 3
• Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological MalignanciesCompletedNCT00660920Phase 1
• Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic InsomniaCompletedNCT00656994Phase 3
• Phase 2 Study of the Safety and Efficacy of LDP-02 in Mildly to Moderately Active Crohn's PatientsCompletedNCT00655135Phase 2
• Efficacy of SYR-472 in Subjects With Type 2 Diabetes MellitusCompletedNCT00653185Phase 2
• A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced MalignanciesTerminatedNCT00652158Phase 1
• Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee ReplacementCompletedNCT00641732Phase 2
• Efficacy and Safety Study of Prucalopride for the Treatment of Chronic ConstipationCompletedNCT00631813Phase 2
• Mifamurtide (L-MTP-PE) for High-Risk OsteosarcomaCompletedNCT00631631
• A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.TerminatedNCT00629876Phase 1
• Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing FacilityCompletedNCT00627692Phase 2
• Efficacy and Safety Study of Prucalopride for the Treatment of Chronic ConstipationCompletedNCT00617513Phase 2
• Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing RegimensWithdrawnNCT00610792Phase 2
• Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic ConstipationCompletedNCT00598338Phase 3
• Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic ConstipationCompletedNCT00596596Phase 2
• STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)CompletedNCT00583518Phase 4
• Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic ConstipationCompletedNCT00577018Phase 3
• Effect of Prucalopride in Patients With Severe Chronic Idiopathic ConstipationCompletedNCT00576511Phase 2

← Takeda overview and focus areas